Autoimmune Diseases  >>  Novartis  >>  Phase 2
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 012345678910
            
            
             
Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap           
          
            
             
gevokizumab (VPM087) / Novartis           
          
            
             
Rixathon (rituximab biosimilar) / Kyowa Kirin, Sandoz           
          
            
             
Jakafi (ruxolitinib) / Incyte           
          
            
             
ligelizumab (QGE031) / Novartis           
          
            
             
selurampanel (BGG492) / Novartis